Objective To assess in rheumatoid arthritis (RA) patients, treated with different immunosuppressive
therapies, the induction of SARS-CoV-2-specific immune response after vaccination …

On 7 January 2020, researchers isolated and sequenced in China from patients with severe
pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide…

A certain number of studies were carried out to address the question of how dysbiosis could
affect the onset and development of rheumatoid arthritis (RA), but little is known about the …

Objective To assess the kinetics of the humoral and cell-mediated responses after severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in rheumatoid arthritis (…

Objective. Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized
as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB …

Twenty-eight patients with low-moderate, stable rheumatoid arthritis (RA), under treatment
with tumor necrosis factor (TNF) α blockers, were immunized at least once with non-…

Objectives To characterize the kinetics of humoral and T-cell responses in rheumatoid arthritis
(RA)-patients followed up to 4-6 weeks (T3) after the SARS-CoV-2 vaccine booster dose. …

In higher vertebrates, mucosal sites at the border between the internal and external
environments, directly interact with bacteria, viruses, and fungi. Through co-evolution, hosts …

Rheumatoid arthritis (RA) is an autoimmune disorder in which gut and oral microbiota play
a crucial role. Diet is a modifiable factor that can influence both microbiota composition and …

Background and aims: Microbiota heterogeneity among humans is mainly due to genetic
background, age, dietary habits, lifestyle and local environments. In this study we investigated …